Search research articles
Contact Us
Filters
Showing results (31-40 of 87) with videos related to
Page
of 9
Sort By:
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
June 21, 2002
Bacterial lipopolysaccharide exposure alters aflatoxin B(1) hepatotoxicity: benchmark dose analysis for markers of liver injury
James P Luyendyk, Kate C Shores, Patricia E Ganey, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
January 20, 2011
Natural killer cells mediate severe liver injury in a murine model of halothane hepatitis
Christine M Dugan, Aaron M Fullerton, Robert A Roth, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 15, 2014
Trovafloxacin potentiation of lipopolysaccharide-induced tumor necrosis factor release from RAW 264.7 cells requires extracellular signal-regulated kinase and c-Jun N-Terminal Kinase
Kyle L Poulsen, Ryan P Albee, Patricia E Ganey, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
August 19, 2007
The role of tumor necrosis factor alpha in lipopolysaccharide/ranitidine-induced inflammatory liver injury
Francis F Tukov, James P Luyendyk, Patricia E Ganey, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
December 6, 2003
15-deoxy prostaglandin J2 enhances allyl alcohol-induced toxicity in rat hepatocytes
Jane F Maddox, Alison C Domzalski, Robert A Roth, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 24, 2002
Underlying endotoxemia augments toxic responses to chlorpromazine: is there a relationship to drug idiosyncrasy?
John P Buchweitz, Patricia E Ganey, Steven J Bursian, et al.
Journal of Toxicology and Environmental Health. Part A
|
July 23, 2002
The temporal relationship between bacterial lipopolysaccharide and monocrotaline exposures influences toxicity: shift in response from hepatotoxicity to nitric oxide-dependent lethality
Steven B Yee, Bryan L Copple, Patricia E Ganey, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 4, 2010
A mouse model of severe halothane hepatitis based on human risk factors
Christine M Dugan, Allen E MacDonald, Robert A Roth, et al.
Chemico-Biological Interactions
|
May 30, 2021
Fenofibrate, a peroxisome proliferator-activated receptor-alpha agonist, blocks steatosis and alters the inflammatory response in a mouse model of inflammation-dioxin interaction
Jesus Olivero-Verbel, Jack R Harkema, Robert A Roth, et al.
Toxicology
|
October 25, 2011
Neutrophil-cytokine interactions in a rat model of sulindac-induced idiosyncratic liver injury
Wei Zou, Robert A Roth, Husam S Younis, et al.
Page
of 9
Search research articles
Search
Showing results (31-40 of 87) with videos related to
Sort By:
Page
of 9
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
June 21, 2002
Bacterial lipopolysaccharide exposure alters aflatoxin B(1) hepatotoxicity: benchmark dose analysis for markers of liver injury
James P Luyendyk, Kate C Shores, Patricia E Ganey, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
January 20, 2011
Natural killer cells mediate severe liver injury in a murine model of halothane hepatitis
Christine M Dugan, Aaron M Fullerton, Robert A Roth, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 15, 2014
Trovafloxacin potentiation of lipopolysaccharide-induced tumor necrosis factor release from RAW 264.7 cells requires extracellular signal-regulated kinase and c-Jun N-Terminal Kinase
Kyle L Poulsen, Ryan P Albee, Patricia E Ganey, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
August 19, 2007
The role of tumor necrosis factor alpha in lipopolysaccharide/ranitidine-induced inflammatory liver injury
Francis F Tukov, James P Luyendyk, Patricia E Ganey, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
December 6, 2003
15-deoxy prostaglandin J2 enhances allyl alcohol-induced toxicity in rat hepatocytes
Jane F Maddox, Alison C Domzalski, Robert A Roth, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 24, 2002
Underlying endotoxemia augments toxic responses to chlorpromazine: is there a relationship to drug idiosyncrasy?
John P Buchweitz, Patricia E Ganey, Steven J Bursian, et al.
Journal of Toxicology and Environmental Health. Part A
|
July 23, 2002
The temporal relationship between bacterial lipopolysaccharide and monocrotaline exposures influences toxicity: shift in response from hepatotoxicity to nitric oxide-dependent lethality
Steven B Yee, Bryan L Copple, Patricia E Ganey, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 4, 2010
A mouse model of severe halothane hepatitis based on human risk factors
Christine M Dugan, Allen E MacDonald, Robert A Roth, et al.
Chemico-Biological Interactions
|
May 30, 2021
Fenofibrate, a peroxisome proliferator-activated receptor-alpha agonist, blocks steatosis and alters the inflammatory response in a mouse model of inflammation-dioxin interaction
Jesus Olivero-Verbel, Jack R Harkema, Robert A Roth, et al.
Toxicology
|
October 25, 2011
Neutrophil-cytokine interactions in a rat model of sulindac-induced idiosyncratic liver injury
Wei Zou, Robert A Roth, Husam S Younis, et al.
Page
of 9